Iqvia Spain company information, Employees & Contact Information

eTMF IQVIA

IQVIA ONEKEY SOLUTIONS IQVIA

FlexView IQVIA

Data-as-a-Service (DaaS) IQVIA

Global Trends in R&D 2025 IQVIA

Pricing and Market Access IQVIA

OneKey HCP Reference Data IQVIA

Brand Strategy and Management IQVIA

The Future of Pharmacovigilance: Integrating AI with Drug Safety Systems IQVIA

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025 Business Wire

The Convergence of Medical Devices and Digital Health: What’s Next? IQVIA

A Brave New World: Six Key Healthcare Industry Trends to Monitor in 2025 for Emerging Biopharma IQVIA

THE BREADTH OF CHEMICAL INTELLIGENCE DATA IQVIA

Forecasting & Franchise Strategy IQVIA

Site and Investigators IQVIA

Navigating an Uncertain Future: Strategic Insights from 2024 Global OTC Performance IQVIA

Primary Intelligence IQVIA

Introducing Rosters & Alignments IQVIA

Inside Agentic AI: Reshaping Decisions and Orchestration in Life Sciences IQVIA

How Early-Stage Planning Strategies Are Optimizing Drug Development IQVIA

Digital Solutions for Obesity: Revolutionising Care and Management IQVIA

Commercial Engagement Services IQVIA

Aim higher and transform trials with Direct-to-Patient Recruitment. IQVIA

INNsight Newsletter IQVIA

Digital Health Trends 2024 IQVIA

Three ways to simplify site processes: Insights from industry leaders at IQVIA Innovation Day, SCOPE Summit 2025 IQVIA

How AI is shaking up compliance in the life sciences industry IQVIA

Transforming Clinical Trial Design Development with Digital Innovation IQVIA

Introducing IQVIA’s Data as a Service (DaaS): A New Era in Data Delivery IQVIA

Forecast Horizon IQVIA

Navigating international data collection for patient organizations IQVIA

Biopharma M&A: Outlook for 2025 IQVIA

Rethinking the tuberculosis response in times of change: The current state of affairs and perspectives on the future IQVIA

How the Lancet Commission and FDA are moving the goal posts in obesity IQVIA

Optimizing Remote Monitoring with FSP IQVIA

Measure Pharma Sales Effectiveness: Understanding the BrandImpact™ Score IQVIA

3 Guiding Principles for Defensible & Impactful AI in Healthcare IQVIA

Overcoming Regulatory Challenges in APAC Cell and Gene Therapy Development IQVIA

Incentive 360 IQVIA

Leveraging Synthetic Control Arms in Clinical Trials and RWE Studies IQVIA

Tuning in: Understanding Healthcare Professionals’ Changing Channel Preferences to Build Better Engagement IQVIA

Why Now is the Time for Patient Data Initiatives IQVIA

2025 Indicators of Progress for the Life Sciences Sector IQVIA

IQVIA Announces CFO Transition in Early 2026 Business Wire

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes Business Wire

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management Business Wire

Doctors and Obesity: Are healthcare professionals ready for the new anti-obesity medications? IQVIA

Chronic Obstructive Pulmonary Disease (COPD) in Malaysia IQVIA

IQVIA Launches New AI Agents for Life Sciences and Healthcare Business Wire

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025 Business Wire

IQVIA Announces Pricing of Senior Notes Business Wire

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’ Business Wire

12,000 Clinical Research Sites Rate IQVIA #1: Global CRO Wins Prestigious WCG Pinnacle Award Stock Titan

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials Business Wire

The Changing Oncology Landscape: Considerations for Patient Organizations IQVIA

In-depth patient insights in obesity highlight the need for a holistic, individualised approach to therapy IQVIA

IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions Business Wire

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm Business Wire

IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025 Business Wire

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials Business Wire

IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services Business Wire

Beyond Healthcare IQVIA

IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year Yahoo Finance

Natural Language Processing IQVIA

IQVIA Releases 2024 Sustainability Report Business Wire

EMEA Data Centralization: A Strategic Approach for Life Sciences IQVIA

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025 Business Wire

Navigating Antimicrobial Resistance IQVIA

Simplifying Digital HCP Engagement: The Seamless Solution for Authentication, Consent and Data Collection IQVIA

The Crucial Role of Real-Time Data Use in Pharma Marketing IQVIA

Clinical Data Analytics Solutions IQVIA

Revolutionizing Life Sciences: The Strategic Edge of Generative AI IQVIA

2024: The obesity market’s inflection point? IQVIA

RNA Therapeutics IQVIA

Safety & Regulatory Compliance Solutions IQVIA

Global Medical Information Services Enhanced by AI/NLP IQVIA

IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing IQVIA

Natural Language Processing (NLP) Insights Hub IQVIA

Tackling tolerability: The next challenge facing obesity therapies IQVIA

Africa’s next chapter: a continent of opportunity IQVIA

The Impact of Biosimilar Competition in Europe 2021 IQVIA

The future of AI in healthcare IQVIA

Harmonized Quality IQVIA

Life Sciences Regulatory Compliance Solutions IQVIA

Data Modernization: Advancing Federal Healthcare Data IQVIA

Drug Safety and Pharmacovigilance IQVIA

RIM Smart - Regulatory Information Management System IQVIA

EMEA Thought Leadership IQVIA

The Cost of the 340B Program Part 1: Self-Insured Employers IQVIA

Real world evidence. Real Confidence. Real Results. IQVIA

Defining Essential Innovative Medicines and Measuring their Use in Europe IQVIA

APAC perspective on Fostering Success in CNS Innovation IQVIA

Patient Support Program IQVIA

Interactive Order Management IQVIA

Advanced Analytics Solution for the Longitudinal Access and Adjudication Data Set IQVIA

Unlocking clinical and commercial success: How PAGs power rare disease research IQVIA

Patient Engagement Suite IQVIA

How will the EU Pharmaceutical revision impact you? IQVIA

Real World & Healthcare Data IQVIA

How rare diseases add up, making them a high public health priority IQVIA